Holzgreve, A., Delker, A., Ells, Z., Brosch-Lenz, J., Unterrainer, L., Nikitas, J., Zhu, S., Contreras, M., Alam, H., Nabong, R., Lira, S., Vasilyev, A., Chen, L., Grogan, T., Elashoff, D., Meyer, C., Dahlbom, M., Czernin, J., Calais, J. (2025). A randomized phase 2 trial of flexible and extended dosing of
            <sup>177</sup>
            Lu-PSMA-617 molecular radioligand therapy in mCRPC (FLEX-MRT): Trial in progress update.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.tps5121